Nalaganje...
Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication
The high efficacy of therapeutic cancer vaccines in preclinical studies has yet to be fully achieved in clinical trials. Tumor immune suppression is a critical factor that hampers the desired antitumor effect. Here, we analyzed the combined effect of a cancer vaccine and the receptor tyrosine kinase...
Shranjeno v:
| izdano v: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404834/ https://ncbi.nlm.nih.gov/pubmed/25949902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.989764 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|